POINT Biopharma
Bill is responsible for all planning, implementation management and operation of all the financial activities of POINT. Previously a senior partner at EY, Bill has over 37 years of professional experience involving a wide range of high-growth companies in the pharmaceutical, manufacturing, and technology sectors, including private and publicly traded Canadian and US NASDAQ listed companies.
This person is not in any offices
POINT Biopharma
POINT Biopharma is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer.